- Home
- VANI vs ZBH Comparison
VANI vs ZBH Comparison
Compare VANI & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ZBH
- Stock Information
- Founded
- VANI 1998
- ZBH 1927
- Country
- VANI United States
- ZBH United States
- Employees
- VANI N/A
- ZBH N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ZBH Industrial Specialties
- Sector
- VANI Health Care
- ZBH Health Care
- Exchange
- VANI Nasdaq
- ZBH Nasdaq
- Market Cap
- VANI 68.1M
- ZBH N/A
- IPO Year
- VANI 2014
- ZBH N/A
- Fundamental
- Price
- VANI $1.26
- ZBH $92.17
- Analyst Decision
- VANI Strong Buy
- ZBH Hold
- Analyst Count
- VANI 1
- ZBH 22
- Target Price
- VANI $4.00
- ZBH $113.55
- AVG Volume (30 Days)
- VANI 66.4K
- ZBH 3.1M
- Earning Date
- VANI 05-13-2025
- ZBH 05-05-2025
- Dividend Yield
- VANI N/A
- ZBH 1.04%
- EPS Growth
- VANI N/A
- ZBH N/A
- EPS
- VANI N/A
- ZBH 4.51
- Revenue
- VANI N/A
- ZBH $7,698,500,000.00
- Revenue This Year
- VANI N/A
- ZBH $7.52
- Revenue Next Year
- VANI N/A
- ZBH $5.55
- P/E Ratio
- VANI N/A
- ZBH $20.45
- Revenue Growth
- VANI N/A
- ZBH 3.30
- 52 Week Low
- VANI $0.91
- ZBH $89.92
- 52 Week High
- VANI $2.09
- ZBH $116.71
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- ZBH 39.41
- Support Level
- VANI $1.13
- ZBH $90.20
- Resistance Level
- VANI $1.16
- ZBH $94.64
- Average True Range (ATR)
- VANI 0.05
- ZBH 2.08
- MACD
- VANI 0.02
- ZBH 0.02
- Stochastic Oscillator
- VANI 92.86
- ZBH 20.35
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.